Monday, April 29, 2013

The Buzz on Royal Jelly

At BeeAlive, we feel our products are superior and serve as nutritious supplements to healthy lifestyles.

To offer substantiation on our views and educate you on the benefits of supplementing with BeeAlive products, we have decided to launch the BeeAlive Weekly Buzz, a series devoted to providing credible studies and articles on various ingredients found in BeeAlive products.

This week, we give you the Buzz on Royal Jelly with a study found on the Memorial Sloan-Kettering website.

Clinical Summary
Royal Jelly is a viscous substance secreted by worker bees and constitutes the essential food for queen bees and their larvae. It is consumed as a health food around the world. It demonstrated vasodilatory, hypotensive, antihypercholesterolemic, antitumor, anti-inflammatory effects and estrogenic activity (1) (3) (9) but its affinity for estrogen receptors is weaker compared to diethylstilbestrol and phytoestrogens (3). Royal Jelly was shown to stimulate MCF-7 cell proliferation which was reversed by tamoxifen (3). It also stimulated the production of collagen as well as other actions needed for bone formation via its action on osteoblasts (4). Royal Jelly may be effective against colitis (10). Oral administration of royal jelly improved testostrerone levels in male rabbits (19). Clinical studies have demonstrated that Royal Jelly lowered total serum lipid levels and total serum cholesterol in individuals with moderately elevated cholesterol levels (5). Mid-cycle peri-coital intravaginal applications of a combination of Egyptian bee honey and Royal Jelly improved infertility due to idiopathic asthenozoospermia (2). In an uncontrolled prospective observational study, Royal Jelly improved menopausal symptoms in postmenopausal women (6).

Royal jelly (RJ) has several physiological effects and is widely used in commercial medical products and health foods. We examined the effects of RJ supplementation on serum lipoprotein metabolism in humans. Fifteen volunteers were divided into an RJ intake group (n=7) and a control group (n=8). The RJ group took 6 g per day for 4 wk. Their serum total cholesterol (TC) and serum low-density lipoprotein (LDL) decreased significantly compared with those of the control group (p<0.05). There were no significant differences in serum high-density lipoprotein (HDL) or triglyceride concentrations. Moreover, the relationship between the serum cholesterol and lipoprotein levels was investigated. Among the lipoprotein fractions, small very-low-density lipoprotein was decreased (p<0.05) after RJ intake. Our results suggest that dietary RJ decreases TC and LDL by lowering small VLDL levels.

Read the full study here. GO ROYAL JELLY!

***These statements have not been evaluated by the Food & Drug Administration. Royal Jelly is not intended to diagnose, treat, cure or prevent any disease. Individual results may vary. Our Royal jelly and other dietary supplements are only meant to be added to the diet as part of a healthy lifestyle; not to treat, cure, prevent or have any effect on any health condition or illness. If you have any concerns, we believe it’s important to work with a healthcare professional.***

No comments:

Post a Comment